837 Shares in Stryker Corporation (NYSE:SYK) Purchased by TFR Capital LLC.

TFR Capital LLC. purchased a new position in shares of Stryker Corporation (NYSE:SYK - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 837 shares of the medical technology company's stock, valued at approximately $312,000.

Other large investors also recently bought and sold shares of the company. Norges Bank purchased a new stake in Stryker during the fourth quarter worth $1,710,744,000. GAMMA Investing LLC grew its stake in shares of Stryker by 43,226.8% during the first quarter. GAMMA Investing LLC now owns 2,074,922 shares of the medical technology company's stock worth $772,390,000 after acquiring an additional 2,070,133 shares during the last quarter. FMR LLC increased its stake in Stryker by 10.0% during the 4th quarter. FMR LLC now owns 8,034,844 shares of the medical technology company's stock valued at $2,892,946,000 after purchasing an additional 727,850 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Stryker in the 4th quarter worth $154,140,000. Finally, Northern Trust Corp lifted its holdings in shares of Stryker by 13.2% during the fourth quarter. Northern Trust Corp now owns 3,606,237 shares of the medical technology company's stock worth $1,298,426,000 after purchasing an additional 420,153 shares during the period. Hedge funds and other institutional investors own 77.09% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Sanford C. Bernstein set a $450.00 price objective on shares of Stryker in a research report on Monday, May 5th. BTIG Research set a $403.00 price objective on shares of Stryker and gave the company a "buy" rating in a report on Monday, April 14th. Citigroup reiterated a "buy" rating and set a $455.00 price objective (up previously from $443.00) on shares of Stryker in a research report on Thursday, May 22nd. Truist Financial increased their price target on shares of Stryker from $390.00 to $400.00 and gave the company a "hold" rating in a research note on Monday, May 5th. Finally, JMP Securities reissued a "market perform" rating on shares of Stryker in a research note on Monday, May 5th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, Stryker has an average rating of "Moderate Buy" and an average price target of $428.55.

Stryker Stock Down 1.4%

Shares of NYSE:SYK traded down $5.53 during midday trading on Friday, hitting $389.24. 825,133 shares of the company's stock traded hands, compared to its average volume of 1,354,569. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.00 and a current ratio of 1.64. Stryker Corporation has a twelve month low of $314.93 and a twelve month high of $406.19. The company has a market cap of $148.57 billion, a PE ratio of 52.60, a P/E/G ratio of 2.94 and a beta of 0.91. The firm's fifty day moving average price is $384.79 and its two-hundred day moving average price is $377.14.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. The company had revenue of $5.87 billion for the quarter, compared to analyst estimates of $5.68 billion. Stryker had a net margin of 12.31% and a return on equity of 23.74%. The business's quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter last year, the firm posted $2.50 earnings per share. On average, equities research analysts anticipate that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.86%. Stryker's dividend payout ratio (DPR) is presently 45.41%.

Insiders Place Their Bets

In other news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the transaction, the director directly owned 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. This represents a 5.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 5.90% of the stock is currently owned by company insiders.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.